[IR 자료] 한국투자증권 NDR — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

IR Materials

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

IR Materials

Nov 20, 2020

[IR 자료] 한국투자증권 NDR

-11월 18일 신한금융투자 설명회 자료와 동일합니다.

에스티팜_IR자료(2020.11.10).pdf